Bharat Biotech gets DCGI nod for phase 3 trials of nasal Covid vaccine

Bharat Biotech gets DCGI nod for phase 3 trials of nasal Covid vaccine

The trials will evaluate the nasal vaccine for both the primary dose schedule as well as the booster one, Bharat Biotech said. Intranasal vaccines are easier to administer in mass immuniaation campaigns and help reduce or stop transmission, the company said. Bharat Biotech on Friday received regulatory approval from the Drugs Controller General of India … Read more

I’m not a vaccine nationalist: Bharat Biotech founder and chairman Dr Krishna Ella

I’m not a vaccine nationalist: Bharat Biotech founder and chairman Dr Krishna Ella

Ella countered this saying that as per the clearance Bharat Biotech would monitor each person getting the vaccine — as they would in a clinical trial. Bharat Biotech’s Covid-19 vaccine, Covaxin, has already been administered to 6,000 volunteers during its Phase 3 trial, the company’s founder and chairman, Dr Krishna Ella, said on Monday. The … Read more